Duopharma Biotech Bhd (XKLS:7148) Total Liabilities : RM667.8 Mil (As of Dec. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Duopharma Biotech Bhd Total Liabilities?

Duopharma Biotech Bhd's Total Liabilities for the quarter that ended in Dec. 2024 was RM667.8 Mil.

Duopharma Biotech Bhd's quarterly Total Liabilities increased from Jun. 2024 (RM649.76 Mil) to Sep. 2024 (RM656.88 Mil) and increased from Sep. 2024 (RM656.88 Mil) to Dec. 2024 (RM667.85 Mil).

Duopharma Biotech Bhd's annual Total Liabilities increased from Dec. 2022 (RM566.70 Mil) to Dec. 2023 (RM658.01 Mil) and increased from Dec. 2023 (RM658.01 Mil) to Dec. 2024 (RM667.85 Mil).

Duopharma Biotech Bhd Total Liabilities Historical Data

The historical data trend for Duopharma Biotech Bhd's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Duopharma Biotech Bhd Total Liabilities Chart

Duopharma Biotech Bhd Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

414.61

540.13

566.70

658.01

667.85

Duopharma Biotech Bhd Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															658.01	631.59	649.76	656.88	667.85

Duopharma Biotech Bhd Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Duopharma Biotech Bhd's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	177.432	+	(464.523	+	23.057
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	2.834)
	=	667.8

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	1376.998	-	709.152
	=	667.8

Duopharma Biotech Bhd's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	177.432	+	(464.523	+	23.057
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	2.834)
	=	667.8

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	1376.998	-	709.152
	=	667.8

Duopharma Biotech Bhd Total Liabilities Related Terms

Thank you for viewing the detailed overview of Duopharma Biotech Bhd's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Duopharma Biotech Bhd Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Duopharma Biotech Bhd (XKLS:7148) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, Klang, SGR, MYS, 41200

Website

https://www.duopharmabiotech.com

Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer, and exporter of pharmaceutical products and medicines.

Duopharma Biotech Bhd Headlines

No Headlines